Celldex Therapeutics, Inc. CLDX 26.15
Health Care · NASDAQ · Data as of 2026-08-06
Celldex Therapeutics, Inc. (CLDX) has delivered -11.9% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1935 of 1968 stocks overall and #252 of 260 in the Health Care sector by Steady Score.
Industry
Diagnostic Substances
Steady Score
26.15
Overall Rank
#1935 / 1968
Sector Rank
#252 / 260
Revenue CAGR
-11.9%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio